152 related articles for article (PubMed ID: 37941514)
1. Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's.
Brimblecombe KR; Connor-Robson N; Bataille CJR; Roberts BM; Gracie C; O'Connor B; Te Water Naude R; Karthik G; Russell AJ; Wade-Martins R; Cragg SJ
Eur J Neurosci; 2024 Mar; 59(6):1242-1259. PubMed ID: 37941514
[TBL] [Abstract][Full Text] [Related]
2. Lower Affinity of Isradipine for L-Type Ca
Ortner NJ; Bock G; Dougalis A; Kharitonova M; Duda J; Hess S; Tuluc P; Pomberger T; Stefanova N; Pitterl F; Ciossek T; Oberacher H; Draheim HJ; Kloppenburg P; Liss B; Striessnig J
J Neurosci; 2017 Jul; 37(28):6761-6777. PubMed ID: 28592699
[TBL] [Abstract][Full Text] [Related]
3. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
[TBL] [Abstract][Full Text] [Related]
4. Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice.
Wang QM; Xu YY; Liu S; Ma ZG
Oncotarget; 2017 Jul; 8(29):47284-47295. PubMed ID: 28521299
[TBL] [Abstract][Full Text] [Related]
5. Calbindin-D28K Limits Dopamine Release in Ventral but Not Dorsal Striatum by Regulating Ca
Brimblecombe KR; Vietti-Michelina S; Platt NJ; Kastli R; Hnieno A; Gracie CJ; Cragg SJ
ACS Chem Neurosci; 2019 Aug; 10(8):3419-3426. PubMed ID: 31361457
[TBL] [Abstract][Full Text] [Related]
6. Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice.
Poetschke C; Dragicevic E; Duda J; Benkert J; Dougalis A; DeZio R; Snutch TP; Striessnig J; Liss B
Sci Rep; 2015 Sep; 5():13688. PubMed ID: 26381090
[TBL] [Abstract][Full Text] [Related]
7. Unbalanced calcium channel activity underlies selective vulnerability of nigrostriatal dopaminergic terminals in Parkinsonian mice.
Sgobio C; Sun L; Ding J; Herms J; Lovinger DM; Cai H
Sci Rep; 2019 Mar; 9(1):4857. PubMed ID: 30890737
[TBL] [Abstract][Full Text] [Related]
8. Gating of dopamine transmission by calcium and axonal N-, Q-, T- and L-type voltage-gated calcium channels differs between striatal domains.
Brimblecombe KR; Gracie CJ; Platt NJ; Cragg SJ
J Physiol; 2015 Feb; 593(4):929-46. PubMed ID: 25533038
[TBL] [Abstract][Full Text] [Related]
9. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
Duda J; Pötschke C; Liss B
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
[TBL] [Abstract][Full Text] [Related]
10. Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol.
Threlfell S; Mohammadi AS; Ryan BJ; Connor-Robson N; Platt NJ; Anand R; Serres F; Sharp T; Bengoa-Vergniory N; Wade-Martins R; Ewing A; Cragg SJ; Brimblecombe KR
Front Cell Neurosci; 2021; 15():658244. PubMed ID: 33935654
[TBL] [Abstract][Full Text] [Related]
11. Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's Disease.
Alarcón-Arís D; Recasens A; Galofré M; Carballo-Carbajal I; Zacchi N; Ruiz-Bronchal E; Pavia-Collado R; Chica R; Ferrés-Coy A; Santos M; Revilla R; Montefeltro A; Fariñas I; Artigas F; Vila M; Bortolozzi A
Mol Ther; 2018 Feb; 26(2):550-567. PubMed ID: 29273501
[TBL] [Abstract][Full Text] [Related]
12. Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release.
Chen BT; Moran KA; Avshalumov MV; Rice ME
J Neurochem; 2006 Feb; 96(3):645-55. PubMed ID: 16405515
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin.
Lieberman OJ; Choi SJ; Kanter E; Saverchenko A; Frier MD; Fiore GM; Wu M; Kondapalli J; Zampese E; Surmeier DJ; Sulzer D; Mosharov EV
eNeuro; 2017; 4(6):. PubMed ID: 29177188
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum.
Cragg S; Rice ME; Greenfield SA
J Neurophysiol; 1997 Feb; 77(2):863-73. PubMed ID: 9065855
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Nigrostriatal Dopamine Release by Striatal GABA
Lopes EF; Roberts BM; Siddorn RE; Clements MA; Cragg SJ
J Neurosci; 2019 Feb; 39(6):1058-1065. PubMed ID: 30541909
[TBL] [Abstract][Full Text] [Related]
16. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
17. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit.
Tozzi A; Sciaccaluga M; Loffredo V; Megaro A; Ledonne A; Cardinale A; Federici M; Bellingacci L; Paciotti S; Ferrari E; La Rocca A; Martini A; Mercuri NB; Gardoni F; Picconi B; Ghiglieri V; De Leonibus E; Calabresi P
Brain; 2021 Dec; 144(11):3477-3491. PubMed ID: 34297092
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.
Longo F; Mercatelli D; Novello S; Arcuri L; Brugnoli A; Vincenzi F; Russo I; Berti G; Mabrouk OS; Kennedy RT; Shimshek DR; Varani K; Bubacco L; Greggio E; Morari M
Acta Neuropathol Commun; 2017 Mar; 5(1):22. PubMed ID: 28292328
[TBL] [Abstract][Full Text] [Related]
19. Dopamine Release Neuroenergetics in Mouse Striatal Slices.
Msackyi M; Chen Y; Tsering W; Wang N; Zhang H
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731799
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.
Faustini G; Longhena F; Bruno A; Bono F; Grigoletto J; La Via L; Barbon A; Casiraghi A; Straniero V; Valoti E; Costantino G; Benfenati F; Missale C; Pizzi M; Spillantini MG; Bellucci A
Neurobiol Dis; 2020 May; 138():104789. PubMed ID: 32032728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
